17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

NCT00132015 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Nonneoplastic Condition
Precancerous Condition

Interventions

DRUG: tanespimycin

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]